Novel Epidermal Recording and Detection of Seizures (NERDS)

September 5, 2018 updated by: M J Harbert, Sharp HealthCare

A Pilot Study of Seizure Detection in Neonates Using Multimodal Temporary Epidermal Electronics

For any newborn that exhibits possible seizure activity or has altered mental status of unknown etiology, continuous bedside EEG recording is the standard of care to detect subclinical seizure activity. The experimental aspect of this study will be the application of test electrodes (EES or EKG) to evaluate if the electrodes can be used to produce a continuous bedside recording of brain activity in the same manner as an EEG recording, while ideally producing less irritation of newborn skin than conventional EEG electrodes.

Study Overview

Status

Terminated

Detailed Description

Infants admitted to our NICU that require a standard EEG for clinical diagnosis will be approached for consent to test one of two new methods of EEG recording. Patients will be randomized to the new epidermal electronic system (EES) or the a hydrogel EKG electrode. All patients will continue to receive the standard of care EEG monitoring.

EES is slim new temporary tattoo technology that can easily be applied to the skin without requiring a technician or scrubbing and preparation as with standard EEG lead. The hydrogel EKG are FDA approved leads normally used to detect cardiac rhythm.

Specific Aims:

  1. To compare the rate of detection of neonatal seizures between a new method of recording electrical brain rhythms (EES or EKG) and the current standard of care (EEG, or electroencephalography.)
  2. To compare characterization of electrical brain activity between EES or EKG and EEG in the neonate.

Study Type

Observational

Enrollment (Actual)

13

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • San Diego, California, United States, 92123
        • Sharp Mary Birch Hospital for Women and Newborns

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 day and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Any newborn admitted to the NICU that requires an EEG for clinical care. Must be less than or equal to 44 weeks corrected gestational age.

Description

Inclusion Criteria:

  • Hospitalized neonates who already require continuous EEG recording for clinical care
  • Parents signed informed consent
  • CGA 44 weeks or less

Exclusion Criteria:

  • Patient is moribund

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Epidermal Electronic System
EES, wireless tattoo electrode
Hydrogel electrode
EKG electrode, looking at hairline placement of electrodes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Seizure detection
Time Frame: 24 hours
Seizures detected by study electrodes will be compared to seizures detected on conventional EEG recording.
24 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
EEG characterization
Time Frame: 24 hours
Compare quality of brain activity with study leads vs standard leads
24 hours
Skin integrity from standard EEG vs study electrodes
Time Frame: 24 hours
Photographs will be taken to compare skin integrity after each electrode use.
24 hours
Hair removal from standard EEG vs study electrodes
Time Frame: 24 hours
If hair removal is necessary for study electrode placement.
24 hours

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gestational age
Time Frame: At birth
At birth
Apgar scores
Time Frame: Birth to 10 minutes of life
Apgars at 1, 5, 10, 15, and 20 minutes of life if applicable
Birth to 10 minutes of life
Subject received hypothermia treatment within 6 hours of life
Time Frame: Within 6 hours of life for 72 hours duration
Within 6 hours of life for 72 hours duration
Cause of seizure if known
Time Frame: Participants will be followed for the duration of hospital stay, an average of 10 days.
Date and time of seizures and etiology
Participants will be followed for the duration of hospital stay, an average of 10 days.
Anticonvulsant medication(s) subject received
Time Frame: Participants will be followed for the duration of hospital stay, an average of 10 days.
Phenobarbital, Levetiracetam, Phosphenytoin, Versed, Blinded Study Drug, Other
Participants will be followed for the duration of hospital stay, an average of 10 days.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Mary J Harbert, MD, Sharp Mary Birch Hospital for Women & Newborns

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 27, 2015

Primary Completion (Actual)

November 3, 2017

Study Registration Dates

First Submitted

March 31, 2015

First Submitted That Met QC Criteria

May 21, 2015

First Posted (Estimate)

May 22, 2015

Study Record Updates

Last Update Posted (Actual)

September 7, 2018

Last Update Submitted That Met QC Criteria

September 5, 2018

Last Verified

September 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • Epidermal Electronics

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe